Does RISANKIZUMAB-RZAA Cause Intervertebral disc protrusion? 194 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 194 reports of Intervertebral disc protrusion have been filed in association with RISANKIZUMAB-RZAA. This represents 0.3% of all adverse event reports for RISANKIZUMAB-RZAA.
194
Reports of Intervertebral disc protrusion with RISANKIZUMAB-RZAA
0.3%
of all RISANKIZUMAB-RZAA reports
0
Deaths
62
Hospitalizations
How Dangerous Is Intervertebral disc protrusion From RISANKIZUMAB-RZAA?
Of the 194 reports, 62 (32.0%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Intervertebral disc protrusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 194 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Intervertebral disc protrusion?
ADALIMUMAB (2,760)
ETANERCEPT (751)
METHOTREXATE (648)
SODIUM OXYBATE (427)
PREGABALIN (415)
TOFACITINIB (393)
UPADACITINIB (384)
INTERFERON BETA-1A (295)
PREDNISONE (285)
SECUKINUMAB (268)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Intervertebral disc protrusion Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA